378 related articles for article (PubMed ID: 30927978)
1. Myeloid disorders after autoimmune disease.
Boddu PC; Zeidan AM
Best Pract Res Clin Haematol; 2019 Mar; 32(1):74-88. PubMed ID: 30927978
[TBL] [Abstract][Full Text] [Related]
2. Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia.
Ertz-Archambault N; Kosiorek H; Taylor GE; Kelemen K; Dueck A; Castro J; Marino R; Gauthier S; Finn L; Sproat LZ; Palmer J; Mesa RA; Al-Kali A; Foran J; Tibes R
JAMA Oncol; 2017 Jul; 3(7):936-943. PubMed ID: 28152123
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia developing in patients with autoimmune diseases.
Ramadan SM; Fouad TM; Summa V; Hasan SKh; Lo-Coco F
Haematologica; 2012 Jun; 97(6):805-17. PubMed ID: 22180424
[TBL] [Abstract][Full Text] [Related]
4. Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents.
Vasquez S; Kavanaugh AF; Schneider NR; Wacholtz MC; Lipsky PE
J Rheumatol; 1992 Oct; 19(10):1625-7. PubMed ID: 1464880
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of acute myeloid leukemias and myelodysplastic syndromes in patients who received thiopurine treatment for inflammatory bowel disease.
Lopez A; Mounier M; Bouvier AM; Carrat F; Maynadié M; Beaugerie L; Peyrin-Biroulet L;
Clin Gastroenterol Hepatol; 2014 Aug; 12(8):1324-9. PubMed ID: 24582568
[TBL] [Abstract][Full Text] [Related]
6. Myeloid neoplasms secondary to plasma cell myeloma: an intrinsic predisposition or therapy-related phenomenon? A clinicopathologic study of 41 cases and correlation of cytogenetic features with treatment regimens.
Reddi DM; Lu CM; Fedoriw G; Liu YC; Wang FF; Ely S; Boswell EL; Louissaint A; Arcasoy MO; Goodman BK; Wang E
Am J Clin Pathol; 2012 Dec; 138(6):855-66. PubMed ID: 23161720
[TBL] [Abstract][Full Text] [Related]
7. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.
Pedersen-Bjergaard J; Philip P; Larsen SO; Andersson M; Daugaard G; Ersbøll J; Hansen SW; Hou-Jensen K; Nielsen D; Sigsgaard TC
Leukemia; 1993 Dec; 7(12):1975-86. PubMed ID: 8255096
[TBL] [Abstract][Full Text] [Related]
8. The evolving challenge of therapy-related myeloid neoplasms.
Churpek JE; Larson RA
Best Pract Res Clin Haematol; 2013 Dec; 26(4):309-17. PubMed ID: 24507808
[TBL] [Abstract][Full Text] [Related]
9. Acute myeloid leukemias with ring sideroblasts show a unique molecular signature straddling secondary acute myeloid leukemia and
Martin-Cabrera P; Jeromin S; Perglerovà K; Haferlach C; Kern W; Haferlach T
Haematologica; 2017 Apr; 102(4):e125-e128. PubMed ID: 28057736
[No Abstract] [Full Text] [Related]
10. Therapy-related myeloid neoplasms: pathobiology and clinical characteristics.
Sill H; Olipitz W; Zebisch A; Schulz E; Wölfler A
Br J Pharmacol; 2011 Feb; 162(4):792-805. PubMed ID: 21039422
[TBL] [Abstract][Full Text] [Related]
11. Azathioprine: association with therapy-related myelodysplastic syndrome and acute myeloid leukemia.
Kwong YL
J Rheumatol; 2010 Mar; 37(3):485-90. PubMed ID: 20080917
[TBL] [Abstract][Full Text] [Related]
12. Therapy-related myeloid neoplasms.
Czader M; Orazi A
Am J Clin Pathol; 2009 Sep; 132(3):410-25. PubMed ID: 19687318
[TBL] [Abstract][Full Text] [Related]
13. Incidence and susceptibility to therapy-related myeloid neoplasms.
Leone G; Fianchi L; Pagano L; Voso MT
Chem Biol Interact; 2010 Mar; 184(1-2):39-45. PubMed ID: 20026017
[TBL] [Abstract][Full Text] [Related]
14. Acute myeloid leukemia after azathioprine treatment for autoimmune diseases: association with -7/7q-.
Kwong YL; Au WY; Liang RH
Cancer Genet Cytogenet; 1998 Jul; 104(2):94-7. PubMed ID: 9666800
[TBL] [Abstract][Full Text] [Related]
15. Therapy-related myeloid neoplasms after treatment for plasma-cell disorders.
Chung A; Liedtke M
Best Pract Res Clin Haematol; 2019 Mar; 32(1):54-64. PubMed ID: 30927976
[TBL] [Abstract][Full Text] [Related]
16. Clonal Hematopoiesis and therapy related MDS/AML.
Desai P; Roboz GJ
Best Pract Res Clin Haematol; 2019 Mar; 32(1):13-23. PubMed ID: 30927970
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.
Geyh S; Rodríguez-Paredes M; Jäger P; Koch A; Bormann F; Gutekunst J; Zilkens C; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
Haematologica; 2018 Sep; 103(9):1462-1471. PubMed ID: 29773599
[TBL] [Abstract][Full Text] [Related]
18. Autoimmunity, Clonal Hematopoiesis, and Myeloid Neoplasms.
Bekele DI; Patnaik MM
Rheum Dis Clin North Am; 2020 Aug; 46(3):429-444. PubMed ID: 32631598
[TBL] [Abstract][Full Text] [Related]
19. When inflammatory stressors dramatically change, disease phenotypes may transform between autoimmune hematopoietic failure and myeloid neoplasms.
Zhao XC; Ju B; Xiu NN; Sun XY; Meng FJ
Front Immunol; 2024; 15():1339971. PubMed ID: 38426096
[TBL] [Abstract][Full Text] [Related]
20. JAK2 double minutes with resultant simultaneous amplification of JAK2 and CD274 in a therapy-related myelodysplastic syndrome evolving into an acute myeloid leukaemia.
Wang HY; Dell'Aquila ML; Dvanajscak Z; Bejar R; Broome HE; Hsi E; Murray SS; Thorson JA
Br J Haematol; 2019 May; 185(3):566-570. PubMed ID: 30132795
[No Abstract] [Full Text] [Related]
[Next] [New Search]
